STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 61 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $3,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $3,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $3,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $3,000 | +50.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $2,000 | +100.0% | 300 | 0.0% | 0.00% | – |
| Q1 2016 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $2,000 | -33.3% | 300 | 0.0% | 0.00% | +100.0% |
| Q3 2015 | $3,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 475,200 | $6,877,000 | 3.03% |
| Avoro Capital Advisors LLC | 475,000 | $6,873,000 | 2.64% |
| VHCP Management, LLC | 451,400 | $6,532,000 | 1.50% |
| Sio Capital Management, LLC | 140,000 | $2,026,000 | 1.15% |
| Opus Point Partners Management, LLC | 75,000 | $1,085,000 | 0.91% |
| Eventide Asset Management | 620,200 | $8,974,000 | 0.68% |
| Telemetry Investments, L.L.C. | 55,000 | $796,000 | 0.44% |
| Healthcare Value Capital, LLC | 25,000 | $362,000 | 0.40% |
| TFS CAPITAL LLC | 259,916 | $3,761,000 | 0.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 672,562 | $9,732,000 | 0.14% |